ArticleScientific reports2025
Pathogenic characteristics of an unencapsulated Streptococcus suis serotype 31 strain isolated from a patient in Thailand.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Multiplex TaqMan qPCR Assay for Rapid Detection ofVeterinary sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Streptococcus suis is a zoonotic pathogen that causes invasive infections in individuals who are in close contact with infected pigs or contaminated pork-derived products. An unencapsulated S. suis serotype 31 strain 43640 (sequence type 221) was first isolated from a human in Thailand in 2015; however, the mechanisms underlying host-cell interactions and virulence in animal models of this serotype are still limited. This study aimed to determine the virulence of the human unencapsulated S. suis serotype 31 strain 43640 using in vitro (A549 epithelial cells) and in vivo (C57BL/6 mouse) models. The adhesion rate of the unencapsulated strain 43640 to A549 cells was significantly lower than that of the highly pathogenic S. suis serotype 2 strain P1/7 after infection at multiplicity of infection (MOI) 1 (p < 0.01) and MOI 10 (p < 0.05). The invasion of epithelial cells by S. suis serotype 31 strain 43640 was significantly higher than that of serotype 2 strain P1/7 and the reference strain 92-4172 4 h after infection. S. suis serotypes 31 and 2 significantly induced cytotoxicity in epithelial cells by more than 50% and 90%, respectively, after 4 h and 18 h of infection. S. suis serotype 31 strain 43640 induced apoptosis in A549 cells via a caspase 9-dependent pathway. Using an in vivo mouse model, we demonstrated that S. suis serotype 31 strain 43640 induced 13.33% and 46.67% mortality due to septicemia after 24 h and 48 h, respectively. Bacterial counts in the blood of mice infected with strain 43640 were significantly lower than those in mice infected with the reference strain 12 h and 24 h after infection (p < 0.05). This study provides information on serotype 31-ST221 virulence in in vitro and in vivo models and proves that ST221 (CC221/234), an emerging human S. suis clone in Thailand, is potentially virulent.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.